Myrexis, Inc. (MYRX)
- Previous Close
0.0105 - Open
0.0105 - Bid --
- Ask --
- Day's Range
0.0105 - 0.0105 - 52 Week Range
0.0003 - 0.0192 - Volume
300 - Avg. Volume
1,084 - Market Cap (intraday)
4.137M - Beta (5Y Monthly) 1.37
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Feb 19, 2013
- 1y Target Est
--
Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.
www.myrexis.comRelated News
Performance Overview: MYRX
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MYRX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MYRX
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-0.25
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-15.06%
Return on Equity (ttm)
-25.67%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-11.62M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
1.21M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-7.31M
Company Insights: MYRX
MYRX does not have Company Insights